By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovering, developing and commercializing therapies derived from or incorporating its RNA-editing6.39M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States6.39M100.00%